AAAAAA
Results: 1-25/71
Authors:
VONLANTHEN S
HEIGHWAY J
TSCHAN MP
BORNER MM
ALTERMATT HJ
KAPPELER A
TOBLER A
FEY MF
THATCHER N
YARBROUGH WG
BETTICHER D
Citation: S. Vonlanthen et al., EXPRESSION OF P16INK4A P16-ALPHA AND P19ARF/P16-BETA IS FREQUENTLY ALTERED IN NONSMALL CELL LUNG-CANCER AND CORRELATES WITH P53 OVEREXPRESSION/, Oncogene, 17(21), 1998, pp. 2779-2785
Authors:
BETTICHER DC
RATSCHILLER D
SCHMITZ SFH
VONROHR A
HESS U
ZULIAN G
WERNLI M
TICHELLI A
TOBLER A
FEY MF
CERNY T
Citation: Dc. Betticher et al., REDUCED DOSE OF SUBCUTANEOUS CLADRIBINE INDUCES IDENTICAL RESPONSE RATES BUT DECREASED TOXICITY IN PRETREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of oncology, 9(7), 1998, pp. 721-726
Authors:
BORNER MM
CASTIGLIONE M
BACCHI M
WEBER W
HERRMANN R
FEY MF
PAGANI O
LEYVRAZ S
MORANT R
PESTALOZZI B
HANSELMANN S
GOLDHIRSCH A
Citation: Mm. Borner et al., THE IMPACT OF ADDING LOW-DOSE LEUCOVORIN TO MONTHLY 5-FLUOROURACIL INADVANCED COLORECTAL-CARCINOMA - RESULTS OF A PHASE-III TRIAL, Annals of oncology, 9(5), 1998, pp. 535-541
Authors:
BORNER MM
MAUER CA
FRIESS H
LUDWIG CU
BUCHLER MW
FEY MF
Citation: Mm. Borner et al., GEMCITABINE (GEM) AND CONTINUOUS-INFUSION FLUOROURACIL (CIF) - A PHASE-II STUDY IN ADVANCED PANCREATIC-CANCER (APC), Annals of oncology, 9, 1998, pp. 241-241
Authors:
BETTICHER DC
VONROHR A
RATSCHILLER D
SCHMITZ SFH
EGGER T
SONDEREGGER T
HERRMANN R
KRONER T
ZULIAN GB
CAVALLI F
FEY MF
CERNY T
Citation: Dc. Betticher et al., FEWER INFECTIONS, BUT MAINTAINED ANTITUMOR-ACTIVITY WITH LOWER-DOSE VERSUS STANDARD-DOSE CLADRIBINE IN PRETREATED LOW-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(3), 1998, pp. 850-858
Authors:
BERCLAZ G
CRAZZOLARA AO
ALTERMATT HJ
AEBI S
FEY MF
HANGGI W
DREHER E
Citation: G. Berclaz et al., SENTINEL LYMPHADENECTOMY - AN ALTERNATIVE TO AXILLARY LYMPHADENECTOMYIN BREAST-CANCER, Schweizerische medizinische Wochenschrift, 128(44), 1998, pp. 1730-1736
Authors:
FEY MF
Citation: Mf. Fey, CANCER AND THE CELL-CYCLE - A CURRENT ARE A OF ONCOLOGICAL RESEARCH WITH CLINICAL RELEVANCE, Schweizerische medizinische Wochenschrift, 128(16), 1998, pp. 629-637
Authors:
FEY MF
BLASER M
WERNLI M
JOTTERAND M
MAIBACH R
GRATWOHL A
TOBLER A
Citation: Mf. Fey et al., SAMPLING BIAS AND LOGISTICAL PROBLEMS OF MOLECULAR ANALYSES IN A CLINICAL LEUKEMIA TRIAL, British Journal of Haematology, 103(2), 1998, pp. 585-587
Authors:
FEY MF
Citation: Mf. Fey, MICROSATELLITE MARKERS IN LEUKEMIA AND LYMPHOMA - COMMENTS ON A TIMELY TOPIC, Leukemia & lymphoma, 28(1-2), 1997, pp. 11-22
Authors:
THURLIMANN B
CASTIGLIONE M
HSUSCHMITZ SF
CAVALLI F
BONNEFOI H
FEY MF
MORANT R
LOHNERT T
GOLDHIRSCH A
Citation: B. Thurlimann et al., FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/, European journal of cancer, 33(7), 1997, pp. 1017-1024
Authors:
ROCHLITZ CF
LOHRI A
SASSEROTH G
VANHILLE B
REUTER J
TICHELLI A
BACCHI M
FOPP M
FEY MF
HERRMANN R
Citation: Cf. Rochlitz et al., MTS1 EXPRESSION AND PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Annals of hematology, 75(4), 1997, pp. 141-144
Authors:
GOLDHIRSCH A
GELBER RD
CASTIGLIONE M
ONEILL A
THURLIMANN B
RUDENSTAM CM
LINDTNER J
COLLINS J
FORBES J
CRIVELLARI D
COATES A
CAVALLI F
SIMONCINI E
FEY MF
PAGANI O
PRICE K
SENN HJ
Citation: A. Goldhirsch et al., MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, Annals of oncology, 8(8), 1997, pp. 751-756
Authors:
FOPP M
FEY MF
BACCHI M
CAVALLI F
GMUER J
JACKY E
SCHMID L
TICHELLI A
TOBLER A
TSCHOPP L
VONFLIEDNER V
GRATWOHL A
Citation: M. Fopp et al., POSTREMISSION THERAPY OF ADULT ACUTE MYELOID-LEUKEMIA - ONE CYCLE OF HIGH-DOSE VERSUS STANDARD-DOSE CYTARABINE, Annals of oncology, 8(3), 1997, pp. 251-257
Authors:
LOHRI A
VANHILLE B
BACCHI M
FOPP M
JONCOURT F
REUTER J
CERNY T
FEY MF
HERRMANN R
Citation: A. Lohri et al., 5 PUTATIVE DRUG-RESISTANCE PARAMETERS (MDR1 P-GLYCOPROTEIN, MDR-ASSOCIATED PROTEIN, GLUTATHIONE-S-TRANSFERASE, BCL-2 AND TOPOISOMERASE II-ALPHA) IN 57 NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIAS/, European journal of haematology, 59(4), 1997, pp. 206-215
Authors:
KOPP P
JAGGI R
TOBLER A
BORISCH B
OESTREICHER M
SABACAN L
JAMESON JL
FEY MF
Citation: P. Kopp et al., CLONAL X-INACTIVATION ANALYSIS OF HUMAN TUMORS USING THE HUMAN ANDROGEN RECEPTOR GENE (HUMARA) POLYMORPHISM - A NONRADIOACTIVE AND SEMIQUANTITATIVE STRATEGY APPLICABLE TO FRESH AND ARCHIVAL TISSUE, Molecular and cellular probes, 11(3), 1997, pp. 217-228
Authors:
SCHWALLER J
PABST T
KOEFFLER HP
NIKLAUS G
LOETSCHER P
FEY MF
TOBLER A
Citation: J. Schwaller et al., EXPRESSION AND REGULATION OF G(1) CELL-CYCLE INHIBITORS (P16(INK4A), P15(INK4B), P18(INK4C), P19(INK4D)) IN HUMAN ACUTE MYELOID-LEUKEMIA AND NORMAL MYELOID CELLS, Leukemia, 11(1), 1997, pp. 54-63
Authors:
LOWENBERG B
BOOGAERTS MA
DAENEN SMGJ
VERHOEF GEG
HAGENBEEK A
VELLENGA E
OSSENKOPPELE GJ
HUIJGENS PC
VERDONCK LF
VANDERLELIE J
WIELENGA JJ
SCHOUTEN HC
GMUR J
GRATWOHL A
HESS U
FEY MF
VANPUTTEN WLJ
Citation: B. Lowenberg et al., VALUE OF DIFFERENT MODALITIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR APPLIED DURING OR AFTER INDUCTION THERAPY OF ACUTE MYELOID-LEUKEMIA, Journal of clinical oncology, 15(12), 1997, pp. 3496-3506
Authors:
FEY MF
TOBLER A
Citation: Mf. Fey et A. Tobler, HEMATOPOIETIC MYELOID GROWTH-FACTORS IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - PLAYERS ON OR OFF STAGE, Onkologie, 20(5), 1997, pp. 372-377
Authors:
TSCHAN M
PETERS UR
OPPLIGER E
FEY MF
TOBLER A
Citation: M. Tschan et al., EXPRESSION PATTERNS OF CELL-CYCLE INHIBITORS IN NORMAL AND LEUKEMIC MYELOPOIESIS, Experimental hematology, 25(8), 1997, pp. 194-194
Authors:
MOTTAZ AE
MARKWALDER R
FEY MF
KLIMA I
MERZ VW
THALMANN GN
BALL RK
STUDER UE
Citation: Ae. Mottaz et al., ABNORMAL P53 EXPRESSION IS RARE IN CLINICALLY LOCALIZED HUMAN PROSTATE-CANCER - COMPARISON BETWEEN IMMUNOHISTOCHEMICAL AND MOLECULAR-DETECTION OF P53 MUTATIONS, The Prostate, 31(4), 1997, pp. 209-215
Authors:
SCHWALLER J
PABST T
BICKEL M
BORISCH B
FEY MF
TOBLER A
Citation: J. Schwaller et al., COMPARATIVE DETECTION AND QUANTITATION OF HUMAN CDK INHIBITOR MESSENGER-RNA EXPRESSION OF P15(INK4B), P16(INK4A), P16-BETA, P18(INK4C), P19(INK4D), P21(WAF1), P27(KIP1) AND P57(KIP2) BY RT-PCR USING A POLYCOMPETITIVE INTERNAL STANDARD, British Journal of Haematology, 99(4), 1997, pp. 896-900
Authors:
BETTICHER DC
SCHMITZ SFH
RATSCHILLER D
VONROHR A
EGGER T
PUGIN P
STALDER M
HESS U
FEY MF
CERNY T
Citation: Dc. Betticher et al., CLADRIBINE (2-CDA) GIVEN AS SUBCUTANEOUS BOLUS INJECTIONS IS ACTIVE IN PRETREATED WALDENSTROMS MACROGLOBULINEMIA, British Journal of Haematology, 99(2), 1997, pp. 358-363
Authors:
SCHWALLER J
PETERS UR
PABST T
NIKLAUS G
MACFARLANE DE
FEY MF
TOBLER A
Citation: J. Schwaller et al., UP-REGULATION OF P21(WAF1) EXPRESSION IN MYELOID CELLS IS ACTIVATED BY THE PROTEIN-KINASE-C PATHWAY, British Journal of Cancer, 76(12), 1997, pp. 1554-1557
Authors:
PETERS UR
HASSE U
OPPLIGER E
TSCHAN M
ONG ST
RASSOOL FV
TOBLER A
FEY MF
Citation: Ur. Peters et al., THE FHIT GENE IS ALTERED IN VARIOUS HEMATOLOGICAL NEOPLASMS, Blood, 90(10), 1997, pp. 2225-2225
Authors:
KOPP P
TOBLER A
OESTREICHER M
JAGGI R
BORISCH B
FEY MF
JAMESON JL
Citation: P. Kopp et al., CLONAL X-CHROMOSOME INACTIVATION ANALYSIS OF HUMAN TUMORS USING A RAPID, NONRADIOACTIVE SEMIQUANTITATIVE PCR-BASED TECHNIQUE THAT ALLOWS ANALYSIS OF FRESH AND ARCHIVAL MATERIAL, Journal of investigative medicine, 44(3), 1996, pp. 333-333